Sleep Initiation and Maintenance Disorders Clinical Trial
Official title:
Effect of Eszopiclone (Lunesta) on Sleep Disturbance and Pain in Cancer
To assess the effectiveness of Lunesta on cancer patients who have received chemotherapy and
who require patient controlled analgesia (PCA), specifically to assess whether Lunesta will:
- improve sleep thereby decreasing need for opiates via PCA
- improve sleep thereby decreasing pain by self report
- improve sleep thereby decreasing fatigue by self report
Pain and fatigue are the most common symptom complaints of cancer patients. Although
dramatic improvements have come about in recognizing and treating cancer related pain, less
progress has been made in treating fatigue. Interventions to improve sleep may offer benefit
in terms of pain and fatigue.
One of the less commonly recognized side effects of opiate use is sleep disruption.
Experimentally-induced sleep disruption lowers the threshold for detection of painful
stimuli. Thus, although opiates are obviously helpful for pain, they do so at certain
"costs": they increase next day fatigue, constipation, and have other side effects; they
disrupt sleep which further increases next day fatigue; and finally, by virtue of their
sleep disruptive properties, they lower the threshold for pain stimuli.
Cancer patients requiring chemotherapy commonly require PCA because of oral mucositis. The
objective of this study is to assess whether opiate usage may be reduced and complaints of
fatigue and pain be lessened if patients had better sleep.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT03276585 -
Night in Japan Home Sleep Monitoring Study
|
||
| Recruiting |
NCT05000528 -
Evaluation of the Effectiveness of Patient Therapeutic Education on Chronic Insomnia
|
N/A | |
| Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
| Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
| Completed |
NCT01784614 -
A Study of LY2624803 in Japanese Participants With Transient Insomnia
|
Phase 1 | |
| Completed |
NCT00380003 -
Efficacy Study of EVT 201 to Treat Insomnia
|
Phase 2 | |
| Completed |
NCT00183378 -
Using Behavioral Programs to Treat Sleep Problems in Individuals With Alzheimer's Disease
|
N/A | |
| Completed |
NCT00097604 -
Effects of Valerian on Sleep in Healthy Older Adults
|
Phase 2 | |
| Completed |
NCT00946530 -
Light Treatment for Sleep/Wake Disturbances in Alzheimer's Disease
|
N/A | |
| Completed |
NCT00630175 -
Evaluation of the Hypnotic Properties of Zolpidem-MR 12.5 mg and Zolpidem 10 mg Marketed Product Compared to Placebo in Patients With Primary Insomnia
|
Phase 3 | |
| Completed |
NCT00044629 -
Combined Behavioral/Pharmacological Therapy for Insomnia
|
Phase 2 | |
| Completed |
NCT00079664 -
Comparing Tai Chi Training to a Low-Stress Physical Activity to Enhance Sleep in Older Adults
|
Phase 1 | |
| Completed |
NCT01154023 -
Behavioral Intervention for Insomnia in Older Adults
|
N/A | |
| Recruiting |
NCT04417153 -
Who Benefits More? Optimising Mindfulness Based Interventions for Improved Psychological Outcomes
|
||
| Completed |
NCT04560595 -
Remote Guided Caffeine Reduction
|
N/A | |
| Recruiting |
NCT04986007 -
Addressing Nocturnal Sleep/Wake Effects on Risk of Suicide in Older Adults
|
N/A | |
| Completed |
NCT03852966 -
Better Sleep in Psychiatric Care - ADHD Pilot Study
|
N/A | |
| Terminated |
NCT00750919 -
Twenty-six Week Extension Trial of Org 50081 (Esmirtazapine) in Outpatients With Chronic Primary Insomnia (176003/P05721/MK-8265-007)
|
Phase 3 | |
| Recruiting |
NCT04550507 -
Mind-Body Interventions to Mitigate Effects of Media Use on Sleep in Early Adolescents
|
N/A | |
| Recruiting |
NCT05226585 -
Mechanisms of Change in Cognitive Behavioral Therapy for Insomnia (CBTi)
|
N/A |